Cargando…
Clinical Study of Advanced Glycation End Products in Egyptian Diabetic Obese and Non-Obese Patients
Advanced glycation end products (AGEs) are complex, heterogenous molecules generated by glycation and oxidation of proteins in vivo, which are thought to markedly increase in diabetic patients. One of the recently identified AGEs is carboxy methyl lysine (CML), which is the main ligand of receptors...
Autores principales: | Amin, Mohamed N., Mosa, Amany A., El-Shishtawy, Mamdouh M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Master Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614834/ https://www.ncbi.nlm.nih.gov/pubmed/23675236 |
Ejemplares similares
-
Serum soluble receptor of advanced glycation end products and risk of metabolic syndrome in Egyptian obese women
por: Zaki, Moushira, et al.
Publicado: (2017) -
The antimicrobial peptide alpha defensin correlates to type 2 diabetes via the advanced glycation end products pathway
por: El-Mowafy, Mohammed, et al.
Publicado: (2022) -
Research Trends in Advanced Glycation End Products and Obesity: Bibliometric Analysis
por: Liman, Patricia Budihartanti, et al.
Publicado: (2022) -
Implications of receptor for advanced glycation end products for progression from obesity to diabetes and from diabetes to cancer
por: Garza-Campos, Andrea, et al.
Publicado: (2023) -
Circulating and dietary advanced glycation end products and obesity in an adult population: A paradox of their detrimental effects in obesity
por: Turki Jalil, Abduladheem, et al.
Publicado: (2022)